Oral chemotherapeutic agents in metastatic hormone-sensitive prostate cancer: A network meta-analysis of randomized controlled trials by Yong Seong Lee, Seong Hwan Kim, Jong Hyun Tae, In Ho Chang, Tae-Hyoung Kim, Soon Chul Myung, Myoungsuk Kim, Tuan Thanh Nguyen, Joongwon Choi, Jung Hoon Kim, Jin Wook Kim, Se Young Choi

Subjects: Get full text

Systemic triplet therapy for metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis by Tengteng Jian, Yang Zhan, Kebang Hu, Liang He, Sunmeng Chen, Rui Hu, Ji Lu

Subjects: Get full text

A New Paradigm in the Systemic Treatment of Advanced Prostate Cancer: the Earlier the Better or the More the Better by Tomislav Omrčen, Jure Murgić

Subjects: Get full text

Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care by Abhenil Mittal, Srikala S. Sridhar, Michael Ong, Di Maria Jiang

Subjects: Get full text

A case of mixed neuroendocrine carcinoma–acinar adenocarcinoma: Utilization of triplet therapy for prostate cancer by Junichi Ikeda, Hisanori Taniguchi, Hiroki Takayama, Yuki Masuo, Takahiro Nakamoto, Katsunori Uchida, Hidefumi Kinoshita

Subjects: Get full text

Combination therapy for high-volume versus low-volume metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis by Tengteng Jian, Yang Zhan, Ying Yu, Kai Yu, Rui Hu, Jixue Wang, Ji Lu

Subjects: Get full text

Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanaly... by Francesco Fiorica, Consuelo Buttigliero, Daniela Grigolato, Marco Muraro, Fabio Turco, Fernando Munoz, Marcello Tucci

Subjects: “…triplet therapy…”
Get full text